NICE guidelines on anti-tumor necrosis factor therapy for RA

Nat Clin Pract Rheumatol. 2009 Jan;5(1):16-7. doi: 10.1038/ncprheum0964. Epub 2008 Dec 2.

Authors

David L Scott¹, Sophia Steer

Affiliation

¹ Department of Rheumatology, King's College Hospital, London, UK. david.l.scott@kcl.ac.uk

PMID: 19048006
DOI: 10.1038/ncprheum0964

No abstract available

MeSH terms

Antirheumatic Agents / economics
Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid / drug therapy*
Arthritis, Rheumatoid / economics
Arthritis, Rheumatoid / physiopathology
Clinical Trials as Topic
Cost-Benefit Analysis
Humans
Joints / physiopathology
Practice Guidelines as Topic*
Severity of Illness Index
Treatment Outcome
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
United Kingdom

Substances

Antirheumatic Agents
Tumor Necrosis Factor-alpha